The Lancet Oncology, 23(6), 818-828. Lancet Publishing Group Kater, A P, Levin, M-D, Dubois, J, Kersting, S, Enggaard, L, Veldhuis, G J, Mous, R, Mellink, C H M, van der Kevie-Kersemaekers, A-M F, Dobber, J A, Poulsen, C B, Frederiksen, H, Janssens, A, Schjødt, I, Dompeling, E C, Ranti, J, Brieghel, C, Mattsson, M, Bellido, M, Tran, H T T, Nasserinejad, K & Niemann, C U 2022, ' Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION) : primary analysis of an open-label, randomised, phase 2 trial ', The Lancet Oncology, vol. 23, no. 6, pp. 818-828 . https://doi.org/10.1016/S1470-2045(22)00220-0 Lancet Oncology, 23(6), 818-828. ELSEVIER SCIENCE INC The Lancet. Oncology, 23(6), 818-828. Lancet Publishing Group
Blood, 137(8), 1117-1120. AMER SOC HEMATOLOGY Niemann, C U, Levin, M-D, Dubois, J, Kersting, S, Enggaard, L, Veldhuis, G J, Mous, R, Mellink, C H M, Dobber, J A, Poulsen, C B, Frederiksen, H, Janssens, A, Schjødt, I, Dompeling, E C, Ranti, J, Mattsson, M, Bellido, M, Tran, H T T, Nasserinejad, K & Kater, A P 2021, ' Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia ', Blood, vol. 137, no. 8, pp. 1117-1120 . https://doi.org/10.1182/blood.2020008608 Blood, 137(8), 1117-1120. American Society of Hematology Niemann, C U, Levin, M-D, Dubois, J, Kersting, S, Enggaard, L, Veldhuis, G J, Mous, R, Mellink, C H M, Dobber, J A, Poulsen, C B, Frederiksen, H, Janssens, A, Schjødt, I, Dompeling, E C, Ranti, J, Mattsson, M, Bellido, M, Tran, H T T, Nasserinejad, K & Kater, A P 2021, ' Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia ', Blood, vol. 137, no. 8, pp. 1117-1120 . https://doi.org/10.1182/blood.2020008608
Molecular oncology. Elsevier Haselager, M V, Thijssen, R, Bax, D, Both, D, de Boer, F, Mackay, S, Dubois, J, Mellink, C, Kater, A P & Eldering, E 2022, ' JAK–STAT signalling shapes the NF-κB response in CLL towards venetoclax sensitivity or resistance via Bcl-XL ', Molecular oncology . https://doi.org/10.1002/1878-0261.13364
Deml, Michael J; Minnema, Julia; Dubois, Julie; Senn, Oliver; Streit, Sven; Rachamin, Yael; Jungo, Katharina Tabea (2022). The impact of the COVID-19 pandemic on the continuity of care for at-risk patients in Swiss primary care settings: A mixed-methods study. Social science & medicine, 298, p. 114858. Elsevier 10.1016/j.socscimed.2022.114858 Social science & medicine, Vol. 298 (2022) P. 114858